Printer Friendly

MERCK, WORLD'S LARGEST PHARMACEUTICAL COMPANY, ORDERS CRAY RESEARCH SUPERCOMPUTER

 MERCK, WORLD'S LARGEST PHARMACEUTICAL COMPANY, ORDERS
 CRAY RESEARCH SUPERCOMPUTER
 New System To Be Primarily Used For Computational
 Chemistry For New Pharmaceutical Products
 SAN FRANCISCO, Calif., April 8 /PRNewswire/ -- Merck and Company (NYSE: MRK), the world's largest pharmaceutical company and Fortune Magazine's "most admired corporation" six years in a row, has ordered and is in the process of installing a CRAY Y-MP 8I system, Cray Research, Inc. (NYSE: CYR), announced today. The Eagan, Minn.-based supercomputer company made this announcement at the American Chemical Society's annual spring conference and exhibition, held here this week.
 This is Merck's first Cray Research system. It is being installed at Merck and Co., Inc. Laboratories in Rahway, N.J., and will be primarily used by the company's research division to support high- performance computing for numerically intensive problems associated with designing new prescription drugs. The CRAY Y-MP 8I system will be used for various aspects of drug design including structural biology and chemistry, two disciplines important to drug discovery. One of the main applications for the supercomputer will be Gaussian, a quantum chemistry software package from Gaussian, Inc.
 "Our decision to purchase a CRAY Y-MP 8I was based on the system's excellent price/performance, its capacity to calculate large problems very quickly, and the high-level technical support available from Cray Research's chemistry and other technical experts," said Dr. Charles Leighton, senior vice president of administration, planning and science policy for the Merck Research Laboratories. "We had saturated our current computational resource. The CRAY Y-MP 8I system will provide our scientists with the capability needed to pursue the science we deem important. Our objective is to achieve a seamless integration of this computer into our heterogeneous computing environment, which includes equipment from vendors such as IBM, Digital, Silicon Graphics, and Apple."
 Merck Research Laboratories has facilities located in the United States, UK, France, Spain, Italy, Japan and Canada. The CRAY Y-MP 8I system will gradually be made accessible to international researchers through Merck's global telecommunications links.
 "Since we sold our first system to this industry in 1984, we have seen increasingly significant use of Cray Research technology for computational chemistry," said Robert Eades, Ph.D., director of chemical industry marketing for Cray Research. "In fact, today we have 11 systems installed that are devoted to chemistry applications. This order from Merck, one of the world's most innovative and reputable companies, confirms our leadership in providing the most useful computational chemistry tools to the worldwide chemical industry."
 Cray Research has 298 systems installed worldwide. Since the beginning of 1991, Cray Research has received 12 orders for systems from organizations that
operate in the chemical/pharmaceutical/materials market. The CRAY Y-MP 8I system, announced one year ago, provides the power of the eight-processor CRAY Y-MP in a very cost-effective single unit; Cray Research has received seven orders for this system.
 Cray Research creates the most powerful, highest-quality computational tools for solving the world's most challenging scientific and industrial problems.
 -0- 4/8/92
 /CONTACT: (At ACS Conference, San Francisco) Mardi Schmieder, cellular phone, 7227626, then dial 612-751-6003; or (Media) Steve Conway, 612-683-7133 or (Financial) Laura Merriam, 612-683-7395, all of Cray Research/
 (CYR MRK) CO: Cray Research, Inc.; Merck and Company ST: California, Minnesota IN: CPR SU:


KH -- MN001 -- 6172 04/08/92 11:00 EDT
COPYRIGHT 1992 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1992 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Apr 8, 1992
Words:547
Previous Article:SPECIALTY STEEL LEADERS SEEK VRA EXTENSION MEETING WITH PRESIDENT BUSH
Next Article:AER LINGUS ANNOUNCES NEW FARES


Related Articles
MINNESOTA SUPERCOMPUTER CENTER ORDERS MOST ADVANCED CRAY RESEARCH SUPERCOMPUTERS
CRAY RESEARCH ANNOUNCES WORKSTATION VERSION OF POPULAR UNICHEM PRODUCT
CRAY RESEARCH DEPARTMENTAL SYSTEMS ATTRACTIVE TO NEW CUSTOMERS Product Line Has Brought Cray More Than 120 New-name Customers, Several New Industries
THE DOW CHEMICAL CO. AND CRAY RESEARCH COLLABORATE TO ADVANCE SUPERCOMPUTER USE FOR CHEMICAL ENGINEERING APPLICATIONS
TAISHO PHARMACEUTICAL CO. LTD IS CRAY RESEARCH'S FIRST CUSTOMER IN JAPANESE PHARMACEUTICAL INDUSTRY
NEW CRAY RESEARCH COMPACT SUPERCOMPUTER SERIES DELIVERS UP TO 12-FOLD PRICE-PERFORMANCE INCREASE
CRAY RESEARCH REPORTS MORE THAN 35 ADVANCE ORDERS FOR NEW LOW-COST CRAY J90 SERIES SUPERCOMPUTERS FROM INDUSTRIAL, GOVERNMENT AND ACADEMIC CUSTOMERS
BAYER AG LEVERKUSEN ORDERS SECOND CRAY SUPERCOMPUTER
CRAY RECEIVES ORDER FROM SOLVAY CHEMICAL
Merck and Company Selects Cray Supercomputers Used in Drug Discovery

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters